XERIS BIOPHARMA HOLDINGS, INC. Employee Count
The employee counts XERIS BIOPHARMA HOLDINGS, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 435; Filing 2026-03-02; Lease expense per employee $27,337.93.
- 2024-12-31: Employees (as filed) 394; Filing 2025-03-06; Lease expense per employee $21,730.96.
- 2023-12-31: Employees (as filed) 377; Filing 2024-03-06; Lease expense per employee $17,702.92.
- 2022-12-31: Employees (as filed) 355; Filing 2023-03-08; Lease expense per employee $7,543.66.
- Available history
- 2021-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 435 full-time | 2026-03-02 | $27,337.93 operating + variable |
| 2024-12-31 | 394 full-time | 2025-03-06 | $21,730.96 operating + variable |
| 2023-12-31 | 377 full-time | 2024-03-06 | $17,702.92 operating + variable |
| 2022-12-31 | 355 full-time | 2023-03-08 | $7,543.66 total lease cost |
| 2021-12-31 | 294 full-time | 2022-03-11 | $8,163.27 lease and rental expense |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |